U.S. awaits word on 2nd vaccine as COVID-19 outbreak worsens
The Food and Drug Administration was evaluating a shot developed by Moderna Inc. and the National Institutes of Health and was expected to give it the green light soon, clearing the way for its use to begin as early as Monday.